Company Stock Information

Company Stock Data | Company Summary in Chinese | Company Press Release (70) | NAI Interview(0) | Company Event(0) | Research Report (0) | Chinese Micro Site | Contact Company
BIODELIVERY SCIENCES INTERNATIONAL INC (NASDAQ:BDSI)
Show Interactive Chart | Add to Portfolio

Stock Info

Last Trade 5.410
Change 0.150
Change (%) 2.7%
Volume 1,590,235
10 Days Avg Vol 1,134,800
3 Months Avg Vol 45,379,000
52 Weeks Lo/Hi $ 7.28 - $ 18.48
YTD Price Gain % -30.4%
10 Wks Moving Avg $ 9
200 Days Moving Avg $ 14
Liquidity Ratio 4,313,000
Market Cap 174,749,311

Related News

TitleDate
BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors07/22/2014
BioDelivery Sciences Announces Completion of Patient Enrollment in its Initial Phase 3 Trial of Clonidine Topical Gel for Painful Diabetic Neuropathy06/26/2014
BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence06/08/2014
BioDelivery Sciences Announces Randomization of Over 50% of Subjects in its Initial Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy05/05/2014

Summary

Contact Info

BioDelivery Sciences's address BioDelivery Sciences
Suite 225 - 4131 ParkLake Avenue
Raleigh NC 27612
BioDelivery Sciences's Telephne number +1 919 582-905
BioDelivery Sciences's fax number +1 919 582-905
BioDelivery Sciences's email account
BioDelivery Sciences's web site http://www.bdsi.com
Dr. Mark A. Sirgo,Pharm.D.